
    
      This study will evaluate the efficacy, safety and PK/PD of ocrelizumab at each dose in
      combination with MTX in patients with active RA. The data from this study will also be
      compared with those from a clinical study of ocrelizumab in patients with active RA that was
      conducted in the U.S.
    
  